522 related articles for article (PubMed ID: 12789150)
1. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.
Navazesh M; Mulligan R; Barrón Y; Redford M; Greenspan D; Alves M; Phelan J;
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):693-8. PubMed ID: 12789150
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women.
Navazesh M; Mulligan R; Komaroff E; Redford M; Greenspan D; Phelan J
J Dent Res; 2000 Jul; 79(7):1502-7. PubMed ID: 11005735
[TBL] [Abstract][Full Text] [Related]
3. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients.
Jainkittivong A; Lin AL; Johnson DA; Langlais RP; Yeh CK
Oral Dis; 2009 Apr; 15(3):229-34. PubMed ID: 19207880
[TBL] [Abstract][Full Text] [Related]
4. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era.
Nittayananta W; Chanowanna N; Jealae S; Nauntofte B; Stoltze K
J Oral Pathol Med; 2010 Jan; 39(1):28-34. PubMed ID: 19709350
[TBL] [Abstract][Full Text] [Related]
5. Alteration in salivary function in early HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Dent Res; 2003 Sep; 82(9):719-24. PubMed ID: 12939357
[TBL] [Abstract][Full Text] [Related]
6. Association between salivary flow rates, oral symptoms, and oral mucosal status.
Kaplan I; Zuk-Paz L; Wolff A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):235-41. PubMed ID: 18417382
[TBL] [Abstract][Full Text] [Related]
7. Major salivary gland output differs between users and non-users of specific medication categories.
Wolff A; Zuk-Paz L; Kaplan I
Gerodontology; 2008 Dec; 25(4):210-6. PubMed ID: 18312369
[TBL] [Abstract][Full Text] [Related]
8. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
9. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).
Navazesh M; Mulligan R; Karim R; Mack WJ; Ram S; Seirawan H; Greenspan J; Greenspan D; Phelan J; Alves M;
Oral Dis; 2009 Jan; 15(1):52-60. PubMed ID: 19017280
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics of participants in the oral health component of the Women's Interagency HIV Study.
Mulligan R; Phelan JA; Brunelle J; Redford M; Pogoda JM; Nelson E; Seirawan H; Greenspan JS; Navazesh M; Greenspan D; Alves ME
Community Dent Oral Epidemiol; 2004 Apr; 32(2):86-98. PubMed ID: 15061857
[TBL] [Abstract][Full Text] [Related]
11. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
Lin AL; Johnson DA; Sims CA; Stephan KT; Yeh CK
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):318-24. PubMed ID: 16920540
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
15. Relationship between xerostomia and salivary flow rates in HIV-infected individuals.
Nittayananta W; Chanowanna N; Pruphetkaew N; Nauntofte B
J Investig Clin Dent; 2013 Aug; 4(3):164-71. PubMed ID: 23857880
[TBL] [Abstract][Full Text] [Related]
16. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine synthesis, muscarinic receptor subtypes, neuropeptides and secretion of ferret salivary glands with special reference to the zygomatic gland.
Khosravani N; Ekman R; Ekström J
Arch Oral Biol; 2007 May; 52(5):417-26. PubMed ID: 17123459
[TBL] [Abstract][Full Text] [Related]
19. Association of salivary flow rate with oral function in a sample of community-dwelling older adults in Japan.
Ikebe K; Sajima H; Kobayashi S; Hata K; Morii K; Nokubi T; Ettinger RL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Aug; 94(2):184-90. PubMed ID: 12221386
[TBL] [Abstract][Full Text] [Related]
20. The effects of electrostimulation on parotid saliva flow: a pilot study.
Hargitai IA; Sherman RG; Strother JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):316-20. PubMed ID: 15716838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
